Authors:
Polsky, D
Willke, RJ
Scott, K
Schulman, KA
Glick, HA
Citation: D. Polsky et al., A comparison of scoring weights for the EuroQol (c) derived from patients and the general public, HEALTH ECON, 10(1), 2001, pp. 27-37
Authors:
Li, ZM
Willke, RJ
Pinto, LA
Rittenhouse, BE
Rybak, MJ
Pleil, AM
Crouch, CW
Hafkin, B
Glick, HA
Citation: Zm. Li et al., Comparison of length of hospital stay for patients with known or suspectedmethicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: A randomized, multicenter trial, PHARMACOTHE, 21(3), 2001, pp. 263-274
Authors:
Weinfurt, KP
Willke, RJ
Glick, HA
Freimuth, WW
Schulman, KA
Citation: Kp. Weinfurt et al., Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients, MED CARE, 38(4), 2000, pp. 404-410
Authors:
Glick, HA
Polsky, D
Willke, RJ
Schulman, KA
Citation: Ha. Glick et al., A comparison of preference assessment instruments used in a clinical trial: responses to the visual analog scale from the EuroQol EQ-5D and the Health Utilities Index (vol 19, pg 265, 1999), MED DECIS M, 19(4), 1999, pp. 511-511
Authors:
Glick, HA
Polsky, D
Willke, RJ
Schulman, KA
Citation: Ha. Glick et al., A comparison of preference assessment instruments used in a clinical trial: Responses to the visual analog scale from the EuroQol EQ-5D and the health utilities index, MED DECIS M, 19(3), 1999, pp. 265-275
Citation: Gr. Parkerson et al., An international comparison of the reliability and responsiveness of the Duke Health Profile for measuring health-related quality of life of patientstreated with alprostadil for erectile dysfunction, MED CARE, 37(1), 1999, pp. 56-67
Authors:
Willke, RJ
Yen, T
Parkerson, GR
Linet, OI
Erder, MH
Glick, HA
Citation: Rj. Willke et al., Quality of life effects of alprostadil therapy for erectile dysfunction: Results of a trial in Europe and South Africa, INT J IMPOT, 10(4), 1998, pp. 239-246